News coverage about Genesis Healthcare (NYSE:GEN) has been trending somewhat positive on Monday, Accern reports. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Genesis Healthcare earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news stories about the company an impact score of 44.1393624371288 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the media headlines that may have impacted Accern Sentiment’s rankings:

Several research analysts have issued reports on GEN shares. ValuEngine upgraded shares of Genesis Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, June 8th. Cantor Fitzgerald started coverage on shares of Genesis Healthcare in a report on Wednesday, July 5th. They set an “overweight” rating for the company. Finally, Royal Bank Of Canada restated a “hold” rating and set a $2.00 price target on shares of Genesis Healthcare in a report on Wednesday, September 13th.

ILLEGAL ACTIVITY NOTICE: “Genesis Healthcare (GEN) Given Media Impact Score of 0.23” was posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at

About Genesis Healthcare

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with's FREE daily email newsletter.